Tyra biosciences to participate at september 2022 investor conferences

Carlsbad, calif. , sept. 8, 2022 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that management will participate at the following investor conferences: h.c.
TYRA Ratings Summary
TYRA Quant Ranking